Close
06 Mar 2024
A Western Australian pharmacist has been reprimanded, suspended for two months, and fined $10,000 for professional misconduct after inappropriate dispensing of anabolic androgenic steroids.
In January 2015, the Pharmacy Board of Australia (the Board) received information about Mr Chetan Anant Hegde, a registered pharmacist, and his dispensing of anabolic androgenic steroids during the period 1 January 2008 to 30 April 2009. The Board referred Mr Hegde, in May 2017, to the State Administrative Tribunal of Western Australia (the tribunal).
In August 2020, the tribunal found Mr Hegde had engaged in professional misconduct in relation to his steroid dispensing and poor record keeping. The tribunal found that Mr Hegde’s steroid dispensing did not accord with recognised therapeutic standards, either in quantities and/or in combinations which:
The tribunal cancelled Mr Hegde’s registration and disqualified him for three years. Mr Hedge appealed the decision, and the penalty was set aside.
Following the appeal, the issue of penalty was reconsidered by the tribunal. In November 2023, the tribunal reprimanded Mr Hegde and imposed a two-month suspension and a fine of $10,000. The tribunal decision sets out the following as factors in the decision making:
The tribunal accepted the serious nature of the risks of Mr Hegde’s conduct and that there was a ready market for the drugs and financial rewards for practitioners who prescribe and dispense them. The tribunal found that Mr Hegde’s dispensing of anabolic androgenic steroids was serious, having occurred over 16 months with dispensing to numerous patients on many occasions.
The tribunal decision acknowledges that the penalty would have been dealt with differently if it was being dealt with at a time closer to the misconduct of the finding of professional misconduct.
The tribunal’s decision was made on 17 November and is available on eCourts Portal of Western Australia.